Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Gabor Kemeny"'
Autor:
Andrew J Armstrong, Santosh Gupta, Patrick Healy, Gabor Kemeny, Beth Leith, Michael R Zalutsky, Charles Spritzer, Catrin Davies, Colin Rothwell, Kathryn Ware, Jason A Somarelli, Kris Wood, Thomas Ribar, Paraskevi Giannakakou, Jiaren Zhang, Drew Gerber, Monika Anand, Wen-Chi Foo, Susan Halabi, Simon G Gregory, Daniel J George
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0216934 (2019)
BackgroundRadium-223 is a targeted alpha-particle therapy that improves survival in men with metastatic castration resistant prostate cancer (mCRPC), particularly in men with elevated serum levels of bone alkaline phosphatase (B-ALP). We hypothesized
Externí odkaz:
https://doaj.org/article/a30bb6a9379947f68513ccbaae968fe8
Autor:
Gabor Kemeny, Gyorgy Alpar
Publikováno v:
Poljoprivreda, Vol 6, Iss 1 (2000)
In the operation of agricultural enterprises, changes should cause an increase in the demand on planning. But, practically just a contrary tendence appears. 35 managers was asked in a standard interview, who found the circumstances quite uncertain
Externí odkaz:
https://doaj.org/article/6c5051f066b54a799569f5b060e21028
Autor:
Andrew J. Armstrong, Simon G. Gregory, Daniel J. George, David M. Nanus, Paraskevi Giannakakou, Monika Anand, Gabor Kemeny, Susan Halabi, Santosh Gupta
Copy number alterations validations in independent publically available clinical datasets. (A) and (B) illustrating the top CTCs DNA genomic alterations were independently validated in 1115 patients from 1154 metastatic prostate cancer biopsy tissue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36fc4bbdaaa6632feaa2c7c6951ec2f3
https://doi.org/10.1158/1541-7786.22527290
https://doi.org/10.1158/1541-7786.22527290
Autor:
Mariano A. Garcia-Blanco, Daniel J. George, Paul K. Marcom, Christina I. Herold, James D. Turnbull, Rhonda L. Bitting, Gabor Kemeny, Sebastian Oltean, Matthew S. Marengo, Andrew J. Armstrong
During cancer progression, malignant cells undergo epithelial-mesenchymal transitions (EMT) and mesenchymal-epithelial transitions (MET) as part of a broad invasion and metastasis program. We previously observed MET events among lung metastases in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f2fd263c442d49ba92516fa1218cf36
https://doi.org/10.1158/1541-7786.c.6542265
https://doi.org/10.1158/1541-7786.c.6542265
Autor:
Andrew J. Armstrong, Simon G. Gregory, Daniel J. George, David M. Nanus, Paraskevi Giannakakou, Monika Anand, Gabor Kemeny, Susan Halabi, Santosh Gupta
Whole-exome sequencing and analysis of CTC-DNA.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3441f5234d7e00844a33a9e5876f96e5
https://doi.org/10.1158/1541-7786.22527260
https://doi.org/10.1158/1541-7786.22527260
Autor:
Andrew J. Armstrong, Mariano A. Garcia-Blanco, Mark Connelly, Herbert I. Hurwitz, Daniel J. George, Sarah Gemberling, Carey Hobbs, Katherine M. Prendergast, Cinthia Pi, Jing Li, Patrick Healy, David S. Hsu, Michael R. Harrison, James L. Abbruzzese, John H. Strickler, Gabor Kemeny, Chandra Rao, Brad Foulk, Rengasamy Boominathan, Tian Zhang
Immunofluorescence characterization of EpCAM and c-MET in cell lines. Immunofluorescence of SNU5, HeLa and SIHA cell lines, with (clockwise from top left of each panel) external c-MET, EpCAM, DAPI from EpCAM slide, and DAPI from c-MET slide.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7049de3339d03a774c7531325244cb04
https://doi.org/10.1158/1541-7786.22515081.v1
https://doi.org/10.1158/1541-7786.22515081.v1
Autor:
Andrew J. Armstrong, Mariano A. Garcia-Blanco, Mark Connelly, Herbert I. Hurwitz, Daniel J. George, Sarah Gemberling, Carey Hobbs, Katherine M. Prendergast, Cinthia Pi, Jing Li, Patrick Healy, David S. Hsu, Michael R. Harrison, James L. Abbruzzese, John H. Strickler, Gabor Kemeny, Chandra Rao, Brad Foulk, Rengasamy Boominathan, Tian Zhang
CD45+/CK+ cells captured with c-MET separated by disease site (2A). Boxplot of all samples from cancer patients versus healthy controls (2B). Representative sample of dual positive cells (2C).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::216faed9fadba3b7f33943650873f728
https://doi.org/10.1158/1541-7786.22515078
https://doi.org/10.1158/1541-7786.22515078
Autor:
Andrew J. Armstrong, Simon G. Gregory, Daniel J. George, David M. Nanus, Paraskevi Giannakakou, Monika Anand, Gabor Kemeny, Susan Halabi, Santosh Gupta
Top pathways enriched at baseline (N=45) and progression (N=28) during ingenuity pathway analysis (IPA, Qiagen). Selection criteria; top genes altered in >=40% of the cases.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98d83ed80e8823f5aaf39d08327e54d9
https://doi.org/10.1158/1541-7786.22527257.v1
https://doi.org/10.1158/1541-7786.22527257.v1
Autor:
Andrew J. Armstrong, Simon G. Gregory, Daniel J. George, David M. Nanus, Paraskevi Giannakakou, Monika Anand, Gabor Kemeny, Susan Halabi, Santosh Gupta
Men with circulating tumor cell (CTC) AR-V7–positive metastatic castration-resistant prostate cancer (mCRPC) have worse outcomes when treated with enzalutamide/abiraterone. However, most men lack CTC AR-V7 detection, and additional predictive bioma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52e408ec581e9baff160073b34c0c37c
https://doi.org/10.1158/1541-7786.c.6545372.v1
https://doi.org/10.1158/1541-7786.c.6545372.v1
Autor:
Mariano A. Garcia-Blanco, Daniel J. George, Paul K. Marcom, Christina I. Herold, James D. Turnbull, Rhonda L. Bitting, Gabor Kemeny, Sebastian Oltean, Matthew S. Marengo, Andrew J. Armstrong
Supplementary Tables 1-4, Figures 1-4 from Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7454a5dcd9622b8c27dc5392c897d3c1
https://doi.org/10.1158/1541-7786.22519047
https://doi.org/10.1158/1541-7786.22519047